|
|
|
|
|
|
|
|
|
|
|
05.11.26 - 13:09
|
Aurora Cannabis Announces Fiscal 2027 Second Quarter Results (Business Wire)
|
|
|
Delivers Net Revenue of $86.0 Million, Including Record International Medical Cannabis Net Revenue of $61.4 Million, Representing a 44% Yoy Increase
Generated Adjusted EBITDA1 of $14.0 Million, With Free Cash Flow1 Outflow Improving by $22.4 Million
Maintains Strong Balance Sheet With $133.0 Million of Cash, Cash Equivalents2 and Short-Term Investments With No Debt
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026.
Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company's announcement on November 3, 2026, that Aurora has entered into a definitive agreement (the “Arrangement Agreement”) with Organigram Global Inc. (“Organigram”) pursuant to which Organigram will acquire all o...
|
|
|
|
|
|
|
|
|
|
|
29.10.26 - 12:06
|
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call (Business Wire)
|
|
|
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will host an investor conference call on Thursday, November 12, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time to discuss its financial results for the second quarter 2027. The Company will report its financial results prior to market open that same morning.
Investor Conference Call Details
DATE:
Thursday, November 12, 2026
TIME:
8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST:
Click Here
Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at www.auroramj.com/investors under "Events".
As a reminder, shareholders are advised to REJECT Curaleaf's Hostile Bid by TAKING NO ACTION and NOT TENDERING...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|